Mycotic aneurysm caused by group B streptococcus: a cautionary tale of management problems and a rare organism. NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Mycotic aneurysm caused by group B streptococcus: a cautionary tale of management problems and a rare organism.

Br J Clin Pract. 1990 Sep;44(9):372-4. Unique Identifier : AIDSLINE MED/91027090
Burnet NG; Wilkinson RC; Evans DS; Surgical Unit, Royal Shrewsbury Hospital, Shropshire.

Abstract: We report a case of mycotic aneurysm of the femoral artery which highlights the diagnostic features and management problems of the condition. Our patient required emergency ligation of the artery for life-threatening haemorrhage and subsequently his leg was not viable. The alternative treatment options of simple ligation and excision versus ligation, excision and immediate bypass grafting of the artery are discussed. The causative organism, beta-haemolytic group B streptococcus (S. Agalactiae), is an extremely rare cause of embolic mycotic aneurysm. This rarity is unexplained and is surprising since this organism is a well-known cause of infective endocarditis, which can be complicated by mycotic aneurysms. Mycotic aneurysms may become more common because of the rise of intravascular drug abuse, which combines the risk factors of vessel trauma, endocarditis and immunosuppression, notably from HIV infection.
Keywords: Aneurysm, Infected/DIAGNOSIS/*SURGERY Case Report Femoral Artery/*SURGERY Human Male Middle Age Streptococcal Infections/DIAGNOSIS/*SURGERY *Streptococcus agalactiae JOURNAL ARTICLEKWDaneurysm,infected/diagnosis/KWDsurgerycasereportfemoralartery/KWDsurgeryhumanmalemiddleagestreptococcalinfections/diagnosis/KWDsurgeryKWDstreptococcusagalactiaejournalarticle
910228
M9120676

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .